Allergic Fungal Sinusitis Imitating an Aggressive Skull Base Lesion in the Setting of Pembrolizumab Immunotherapy.
CONCLUSIONS: Inflammatory sinusitis in patients receiving anti-PD-1 therapy may be secondary to T-cell infiltration, a similar pathophysiology as immune-related adverse events, and warrants appreciation by otolaryngologists given our increasing exposure to immunotherapy and its head and neck manifestations.
PMID: 32597680 [PubMed - as supplied by publisher]
Source: The Annals of Otology, Rhinology, and Laryngology - Category: ENT & OMF Authors: Krane NA, Beswick DM, Sauer D, Detwiller K, Shindo M Tags: Ann Otol Rhinol Laryngol Source Type: research
More News: Allergy & Immunology | Aspergillus | Brain | Cancer & Oncology | ENT & OMF | Headache | Immunotherapy | Melanoma | Microbiology | Neurology | Sinusitis | Skin Cancer